Chinese Journal of Antituberculosis ›› 2019, Vol. 41 ›› Issue (3): 315-321.doi: 10.3969/j.issn.1000-6621.2019.03.013
• Original Articles • Previous Articles Next Articles
Ying PENG,Lu TANG,Xin-fa PEI,Xue-ZHi ZHANG,Bai-feng LIN,Li CHEN,Yan-ling YU,Fa-bin LI()
Received:
2018-09-11
Online:
2019-03-10
Published:
2019-03-15
Contact:
Fa-bin LI
E-mail:hljlfb@163.com
Ying PENG,Lu TANG,Xin-fa PEI,Xue-ZHi ZHANG,Bai-feng LIN,Li CHEN,Yan-ling YU,Fa-bin LI. Genotypic and transmission characteristics of Mycobacterium tuberculosis in Wuchang City, Heilongjiang Province[J]. Chinese Journal of Antituberculosis, 2019, 41(3): 315-321. doi: 10.3969/j.issn.1000-6621.2019.03.013
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.zgflzz.cn/EN/10.3969/j.issn.1000-6621.2019.03.013
位点名称 | PCR 引物序列 (5'-3') | 片段及重复 大小(bp) |
---|---|---|
QUB11a | CCCATCCCGCTTAGCACATTCGTA TTGAGGGGGATCCGGGA | 159+69 |
QUB-18 | ATCGTCAGCTGCGGAATGT AATACCGGGGATATCGGTTC | 182+78 |
VNTR3820 | TGCGCGGTGAATGAGACG ACCTTCATCCTTGGCGAC | 245+57 |
QUB-11b | CGTAAGGGGGATGCGGGAAATAGG CGAAGTGAATGGTGGCAT | 67+69 |
MIRU26 | GCGGATAGGTCTACCGTCGAAATC TCCGGGTCATACAGCATGATCA | 243+48 |
QUB-26 | AACGCTCAGCTGTCGGAT GGCCAGGTCCTTCCCGAT | 129+111 |
Mtub21 | AGATCCCAGTTGTCGTCGTC CAACATCGCCTGGTTCTGTA | 92+57 |
药物 | 耐药[株 (耐药率, %)] | 北京基因型(101株) | 非北京基因型(20株) | χ2 值 | P值 | |||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
耐药[株(耐 药率,%)] | Ⅰ群 (株) | Ⅱ群 (株) | Ⅲ群 (株) | 耐药[株(耐 药率,%)] | Ⅰ群 (株) | Ⅱ群 (株) | Ⅲ群 (株) | |||||
INH | 7(5.8) | 5(5.0) | 0 | 5 | 0 | 2(10.0) | 0 | 2 | 0 | 0.781 | 0.377 | |
RFP | 4(3.3) | 3(3.0) | 0 | 3 | 0 | 1(5.0) | 0 | 1 | 0 | 0.215 | 0.643 | |
EMB | 6(5.0) | 6(5.9) | 1 | 3 | 2 | 0(0.0) | 0 | 0 | 0 | 1.250 | 0.264 | |
Sm | 19(15.7) | 18(17.8) | 4 | 13 | 1 | 1(5.0) | 0 | 1 | 0 | 2.073 | 0.150 | |
合计 | 36(29.8) | 32(31.7) | 5 | 24 | 3 | 4(20.0) | 0 | 4 | 0 | 1.090 | 0.296 |
[1] | van Soolingen D, Qian L, de Haas PE , et al. Predominance of a single genotype of Mycobacterium tuberculosis in countries of east Asia. J Clin Miclobiol, 1995,33(12):3234-3238. |
[2] |
Coll F, McNerney R, Guerra-Assunção JA , et al. A robust SNP barcode for typing Mycobacterium tuberculosis complex strains. Nat Commun, 2014,5:4812.
doi: 10.1038/ncomms5812 URL pmid: 4166679 |
[3] |
罗涛, 杨崇广, 逄宇 , 等. 建立适合我国结核分枝杆菌特征的可变串联重复序列(VNTR)分型方法(本专业在国外发表的重要论文简介). 中华结核和呼吸杂志, 2014,37(5):322.
doi: 10.3760/cma.j.issn.1001-0939.05.002 URL |
[4] |
Oelemann MC, Diel R, Vatin V , et al. Assessment of an optimized mycobacterial interspersed repetitive-unit-variable-number tandem-repeat typing system combined with spoligotyping for population-based molecular epidemiology studies of tuberculosis. J Clin Microbiol, 2007,45(3):691-697.
doi: 10.1128/JCM.01393-06 URL pmid: 1829086 |
[5] |
Tsolaki AG, Gagneux S, Pym AS , et al. Genomic deletions classify the Beijing/W strains as a distinct genetic lineage of Mycobacterium tuberculosis. J Clin Microbiol, 2005,43(7):3185-3191.
doi: 10.1128/JCM.43.7.3185-3191.2005 URL pmid: 1169157 |
[6] |
张灿灿, 黄海荣, 高飞 , 等. 结核分枝杆菌VNTRs位点的研究进展. 临床肺科杂志, 2015,20(12):2277-2280.
doi: 10.3969/j.issn.1009-6663.2015.12.045 URL |
[7] |
Zhao Y, Xu S, Wang L , et al. National survey of drug-resis-tant tuberculosis in China. N Engl J Med, 2012,366(23):2161-2170.
doi: 10.1056/NEJMoa1108789 URL pmid: 22670902 |
[8] |
Pang Y, Zhou Y, Zhao B , et al. Spoligotyping and drug resistance analysis of Mycobacterium tuberculosis strains from national survey in China. PLoS One, 2012,7(3):e32976.
doi: 10.1371/journal.pone.0032976 URL pmid: 22412962 |
[9] |
Liu Y, Tian M, Wang X , et al. Genotypic diversity analysis of Mycobacterium tuberculosis strains collected from Beijing in 2009, using spoligotyping and VNTR typing. PLoS One, 2014,9(9):e106787.
doi: 10.1371/journal.pone.0106787 URL pmid: 25237849 |
[10] |
Chen YY, Chang JR, Kuo SC , et al. Molecular epidemiology of tuberculosis in Kaohsiung City located at southern Taiwan, 2000—2008. PLoS One, 2015,10(1):e0117061.
doi: 10.1371/journal.pone.0117061 URL pmid: 25629610 |
[11] |
Wang Q, Lau SK, Liu F , et al. Molecular epidemiology and clinical characteristics of drug-resistant Mycobacterium tuberculosis in a tuberculosis referral hospital in China. PLoS One, 2014,9(10):e110209.
doi: 10.1371/journal.pone.0110209 URL pmid: 4193878 |
[12] |
包海洋, 曹旭东, 秦莲花 , 等. 北疆地区结核分枝杆菌基因分型及耐药性分析. 中国防痨杂志, 2016,38(2):110-115.
doi: 10.3969/j.issn.1000-6621.2016.02.008 URL |
[13] |
刘梅, 罗涛, 杨崇广 , 等. 不同可变数目串联重复序列组合鉴定结核分枝杆菌临床菌株分型的效果. 中华结核和呼吸杂志, 2015,38(10):746-750.
doi: 10.3760/cma.j.issn.1001-0939.2015.10.006 URL |
[14] |
Zhang L, Chen J, Shen X , et al. Highly polymorphic variable-number tandem repeats loci for differentiating Beijing genotype strains of Mycobacterium tuberculosis in Shanghai, China. FEMS Microbiol Lett, 2008,282(1):22-31.
doi: 10.1111/j.1574-6968.2008.01081.x URL pmid: 18336551 |
[15] | 杨洪毅, 李辉, 马士文 , 等. MIRU-VNTR技术对源于河南的北京基因型结核分枝杆菌分型研究. 中国卫生检验杂志, 2010,20(6):1305-1307,1353. |
[1] | Tuberculosis Control Branch of Chinese Antituberculosis Association, The Youth Branch of Chinese Antituberculosis Association, Editorial Board of Chinese Journal of Antituberculosis. Evidence-based guidelines for application of digital adherence technology in tuberculosis medication management in China [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 385-397. |
[2] | Li Jinhao, Hu Dongmei, Xu Caihong. Investigation on the willingness of tuberculosis health-care workers to implement tuberculosis preventive treatment and analysis of influencing factors [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 398-407. |
[3] | Li Yuhong, Mei Jinzhou, Su Wei, Ruan Yunzhou, Liu Yushu, Zhao Yanlin, Liu Xiaoqiu. Analysis of the treatment outcomes and influencing factors of rifampicin-resistant pulmonary tuberculosis patients aged 65 and above in China from 2015 to 2021 [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 408-415. |
[4] | Jiang Xue, Bai Yunlong, Ma Jianjun, An Yuan, Yang Fan, Zhao Qinglong. Status and influencing factors of diagnosis and treatment delay of rifampicin resistant pulmonary tuberculosis patients, Jilin Province, 2020—2023 [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 416-424. |
[5] | Wu Xuan, Zhang Yanqiu, Xu Jiying, Meng Dan, Sun Dingyong. Analysis of factors influencing the treatment outcomes of patients with pulmonary tuberculosis and diabetes mellitus in Henan Province (2019—2023) [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 425-431. |
[6] | An Yuan, Bai Yunlong, Zhao Qinglong, Ma Jianjun, Jiang Xue, Pan Yan, Gao Ying, Gao Zhihui. Analysis of treatment outcomes and influencing factors of patients with pulmonary tuberculosis complicated with diabetes mellitus in Jilin Province,2018—2022 [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 432-438. |
[7] | Feng Wei, Zheng Hailun, Meng Weili, Luo Ping. Analysis of under-reporting before arrival of pulmonary tuberculosis patients registered and managed by Tuberculosis Prevention and Control Institutions in Xicheng District, Beijing from 2018 to 2023 [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 439-443. |
[8] | Hu Yifan, Du Boping, Wu Yadong, Zhu Chuanzhi, Zhang Lanyue, Jia Hongyan, Sun Qi, Pan Liping, Zhang Zongde, Li Zihui. Experimental study on the role of Mce4C in the uptake and utilization of cholesterol by Mycobacterium tuberculosis [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 444-453. |
[9] | Sheng Jie, Hong Kaifeng, Mierzhati Aisha, Tang Wei, Dilixiati Abulizi. Study on the mechanism of IL-22 and p38 MAPK signaling pathways in inhibiting bone destruction in bone and joint tuberculosis [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 454-459. |
[10] | Wang Yingchao, Liu Weiyi, Ji Xiuxiu, Shang Xuetian, Jia Hongyan, Zhang Lanyue, Sun Qi, Du Boping, Zhu Chuanzhi, Pan Liping, Zhang Zongde. Profile analysis of circRNA expression and identification of diagnostic markers in peripheral blood mononuclear cells of tuberculosis patients [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 460-470. |
[11] | Zhu Mingzhi, Shao Yanqin, Fan Dapeng, Liu Libin, Mei Bin, Dai Lingshan, Cai Long. Diagnostic value of urine lipoarabinomannan antigen detection in extrapulmonary tuberculosis [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 471-476. |
[12] | Hao Mingxiao, Mi Jie, Xu Zongyi. Effectiveness of a continuity of care model in patients with tuberculous meningitis [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 477-481. |
[13] | Shang Xiyu, Zhang Huifang, Cao Yuqing, Xiong Yibai, Ji Xinyu, Tian Yaxin, Li Jiajia, Wang Ni, Ma Yan. Bibliometric analysis of global research status and hotspots in the basic research of Traditional Chinese Medicine for tuberculosis [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 482-497. |
[14] | Qin Lili, Yang Chengqing, Mai Hongzhen, Xu Qifeng, Xue Xinying, Lu Xiwei. Advances in the clinical diagnosis and treatment of post-tuberculosis chronic pulmonary aspergillosis [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 498-504. |
[15] | Luo Li, Luo Linzi, Yin Quhua, Zhou Lei, Lu Zhibin, Ding Yan, Xiao Yangbao. Progress in bronchoscopic diagnosis and treatment of lymph node fistula tracheobronchial tuberculosis [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 505-512. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||